Jeffrey L. Ives, Director at Cara Therapeutics, Inc. (CARA), sold 2,500 shares at $18.21 ($46K) on 2019-10-01, disclosed to the SEC on 2019-10-03.
Scheduled sale ($46k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2021-11-16 | $262K | — | Filing → |
| CARA | SELL | 2021-06-07 | $33K | — | Filing → |
| CARA | SELL | 2020-11-24 | $39K | — | Filing → |